The Biosimilar Contract Manufacturing Market is estimated to be valued at US$ 10.70 Bn in 2024 and is expected to exhibit a CAGR of 15.9% over the forecast period 2024- 2031, as highlighted in a new report published by Coherent Market Insights. The growth of the biosimilar contract manufacturing market is attributed to the increasing prevalence of Read More…
